CDC News

Wyoming, Louisiana, and Oklahoma have the lowest percentage of population with shots in arms based on state population. Is your state among the other 7?

The 3% decline in 2023 compared with 2022 is "heartening news," CDC's Houry says, but the mission is far from accomplished.

The updated guidelines reflect the progress made in protecting against severe illness from COVID-19, said CDC Director Mandy Cohen, MD, MPH.

COVID-19 hospitalizations have never fall below 6000/week, according to the ACIP; those aged 65+ have the highest inpatient rate, those aged 75+ have the highest mortality.

Reported cases of chlamydia, syphilis, and gonorrhea in the US surpassed 2.5 million for the third time in 5 years, according to CDC.

Measles cases are reported in 6 states, which is not a surprise to one pediatrician who points to the ongoing consequences of falling vaccination rates.

Infections with the JN.1 Omicron descendent have doubled since mid-November and now comprise 1 in 5 cases of COVID-19 in the US.

Vaccination against all 3 cocirculating viruses are lower than this time last year and hospitalizations are up across age groups, according to a CDC Health Advisory.

The 100 mg dose prefilled syringes are in particularly short supply and while the shortage of the 50 mg dose is not as severe, supply will be limited this season.

A 2-question quiz on the ACIP's recommendations on the new COVID-19 monovalent vaccines that provide protection from currently circulating strains.

Members of the ACIP voted on Friday to recommend Pfizer’s maternal bivalent RSVpreF vaccine to protect newborns from severe RSV illness.

The CDC update recommends ending screening strategies that require multiple clinic visits for sample collection, favoring 1 visit and automatic HCV RNA testing.

The 2 new vaccines are authorized for adults aged 60 years and older and with CDC Director Walensky's final nod, should be available this fall.

Overdose deaths involving heroin and oxycodone decreased during this time, according to new report.

Onset of the 2022-2023 RSV season and its end were closer to historical patterns but atypical circulation may continue, say researchers writing in MMWR.

Drug-resistant cases of Candida auris continue to spread across the US after an alarming 95% rise in cases of the fungal infection in 2021.

Get a quick topline look at specific revisions and additions included in the ACIP's recommendations for routine immunization of those aged ≥19 years in the US.

Preliminary estimates showed relative bivalent booster dose vaccine effectiveness against XBB/XBB.1.5 for at least the first 3 months after vaccination.

Get up-to-date on the newest guidance for clinicians managing acute, subacute, and chronic pain in adults with this quick quiz.

Among the CDC vaccine advisory group's recommendations are adding COVID-19 vaccines to the Vaccine for Children program and allowing PCV20 shots for those who previously received PCV13.

One study showed the boosters provide significant protection against hospitalization and ED care and the other found vaccine effectiveness of 84% in older adults.

Your daily dose of clinical news you may have missed.

The inpatient flu census doubled after Thanksgiving travel and gatherings and ICU beds are full. More at-a-glance stats on Flu in the USA, here.

Flu rates are up after the Thanksgiving holiday week, COVID-19 hospitalizations are increasing, and RSV may or may not be on the wane as Christmas approaches.

A guideline topline of the CDC's 2022 clinical guidance for prescribing opioids for pain in adults.

The 2022 guidance covers acute, subacute, and chronic pain and replaces the 2016 guidelines.

Get answers to 7 questions you may have regarding bivalent booster dose vaccination for patients from the US Centers for Disease Control and Prevention.

Respiratory virus season is top of mind for Schaffner, medical director of the National Foundation for Infectious Diseases, and he says it's going to be a challenge.

The CDC's COVID-19 pandemic response was cited as a key factor driving plans to increase the agency's responsiveness and accountability.

After exposure to COVID-19, asymptomatic individuals in low-risk settings no longer need to quarantine, says the CDC; masking is still recommended.